The ERA Registry Annual Report 2019: summary and age comparisons
Status PubMed-not-MEDLINE Language English Country England, Great Britain Media electronic-ecollection
Document type Journal Article
PubMed
35211303
PubMed Central
PMC8862051
DOI
10.1093/ckj/sfab273
PII: sfab273
Knihovny.cz E-resources
- Keywords
- ESRD, dialysis, epidemiology, graft survival, kidney transplantation, patient survival,
- Publication type
- Journal Article MeSH
BACKGROUND: Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. METHODS: Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. RESULTS: In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.
Clinical Center of Montenegro Clinic for Nephrology Podgorica Montenegro
Complejo Hospitalario de Navarra Pamplona Navarra Spain
Cyprus Renal Registry Nicosia Cyprus
Department of Internal Medicine of Tartu University and Tartu University Hospital Tartu Estonia
Department of Medicine General University Hospital Prague Strahov Czech Republic
Department of Medicine Holbaek Hospital Holbaek Denmark
Department of Nephrology and Hypertension IIS Fundacion Jimenez Diaz UAM Madrid Spain
Department of Nephrology Cerrahpaşa Medical Faculty Istanbul University Cerrahpaşa Istanbul Turkey
Department of Nephrology University of Helsinki and Helsinki University Hospital Helsinki Finland
Division of Nephrology Landspitali The National University Hospital of Iceland Reykjavik Iceland
Division of Population Health and Genomics School of Medicine University of Dundee Dundee UK
Israel Renal Registry Ramat Gan Israel
Nephrology Department Hospital San Pedro Logroño La Rioja Spain
Oficina Regional de Coordinación de Trasplantes Madrid Region Spain
Portuguese Society of Nephrology Coimbra Portugal
REIN Registry Agence de la Biomédecine Saint Denis La Plaine France
RERCA Public Health Directorate Asturias Spain
Servei Nefrologia Fundació Puigvert Barcelona Catalonia Spain
Service of Nephrology UHC Mother Teresa Tirana Albania
Society of Nephrology and Dialysis of Bosnia and Herzegovina Sarajevo Bosnia and Herzegovina
Swedish Renal Registry Department of Internal Medicine Jonkoping Regional Hospital Jonkoping Sweden
The Norwegian Renal Registry Oslo University Hospital Rikshospitalet Oslo Norway
doi: 10.1093/ckj/sfab274 PubMed
See more in PubMed
Kramer A, Boenink R, Stel VSet al. . The ERA-EDTA Registry Annual Report 2018: a summary. Clin Kidney J 2021; 14: 107–123 PubMed PMC
Eurostat . Demography, Population Stock and Balance-Population National Level. https://ec.europa.eu/eurostat/web/main/data/database (August 2021, date last accessed)